))
Why Dr. Rakesh N. Veedu specialises in oligonucleotide therapeutics and how he started SynGenis in response to the pandemic
Manage episode 340849246 series 3263602
Content provided by The Perth Business Podcast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Perth Business Podcast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.
In this episode, we had the pleasure of speaking with Dr Rakesh N. Veedu on the topic of oligonucleotide therapeutics. If you're drawing a blank, we bet you've heard of the scientific pursuits into finding cures for HIV infection, macular degeneration, and spinal muscular atrophy.
What about the endeavour to protect humanity against Covid?
That one's pretty fresh and don't worry, we don't have divisive discussion around whether or not the vaccine is effective in the context of the current climate. We simply talk facts and get into the nitty gritty of how scientists manufacture DNA and RNA in order to diagnose and treat conditions beyond our comprehension.
It's fascinating and I hope you'll join me in the conversation with DR Rakesh. Drop your notes on your preferred channels or find us on social media or via email at theperthbusinesspodcast@gmail.com.
94 episoade
Distribuie
